Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-014612
Filing Date
2023-03-02
Accepted
2023-03-02 16:09:42
Documents
1
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6933
  Complete submission text file 0001209191-23-014612.txt   8303
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Issuer) CIK: 0001785345 (see all company filings)

EIN.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LANDOS BIOPHARMA, INC. 1800 KRAFT DRIVE, SUITE 216 BLACKBURG VA 24060
Business Address
Truesdell Patrick (Reporting) CIK: 0001930771 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39971 | Film No.: 23698993